SCHEMBL4735227

SCHEMBL4735227

CCOC1CC[C@@]2(C)C(CC[C@H]3[C@@H]4CC[C@H]([C@H](C)CCCC(C)C)[C@@]4(C)CC[C@@H]32)C1

nearest known ligand 0.78

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
CDC25A P30304 4/20 0.78
POLA1 P09884 1/20 0.78
CYP2D6 P10635 1/20 0.71
CYP2C19 P33261 1/20 0.71
INPP5D Q92835 1/20 0.70
ST6GAL1 P15907 2/20 0.60
VDR P11473 3/20 0.57
USP2 O75604 1/20 0.57
FOLH1 Q04609 2/20 0.57
OSBP P22059 1/20 0.56
OSBP2 Q969R2 1/20 0.56
ABCC4 O15439 1/20 0.56
FGF1 P05230 1/20 0.55
HPSE Q9Y251 1/20 0.55

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26693323 1.00 CDC25A (0.78) CDC25APOLA1CYP2D6CYP2C19INPP5D
SCHEMBL13083162 1.00 CDC25A (0.78) CDC25APOLA1CYP2D6CYP2C19INPP5D
SCHEMBL26912861 1.00 CDC25A (0.78) CDC25APOLA1CYP2D6CYP2C19INPP5D
SCHEMBL19184920 1.00 CDC25A (0.78) CDC25APOLA1CYP2D6CYP2C19INPP5D
SCHEMBL11994855 1.00 CDC25A (0.78) CDC25APOLA1CYP2D6CYP2C19INPP5D
SCHEMBL23813359 1.00 CDC25A (0.78) CDC25APOLA1CYP2D6CYP2C19INPP5D
SCHEMBL10017499 0.93 CDC25A (0.68) CDC25APOLA1CYP2D6CYP2C19INPP5D
SCHEMBL12086538 0.93 CDC25A (0.74) CDC25APOLA1CYP2D6CYP2C19INPP5D
SCHEMBL15113084 0.93 CDC25A (0.74) CDC25APOLA1CYP2D6CYP2C19INPP5D
SCHEMBL4739096 0.93 CDC25A (0.74) CDC25APOLA1CYP2D6CYP2C19INPP5D

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2008077247-A1 COATINGS FOR IMPLANTABLE MEDICAL DEVICES COMPRISING CHOLESTEROL MIV THERAPEUTICS INC. (CA) 2008-07-03 WO disclosed